Cell based therapy in Parkinsonism

Parkinson’s disease (PD) is a synucleinopathy-induced chronic progressive neurodegenerative disorder, worldwide affecting about 5 million humans. As of yet, actual therapies are symptomatic, and neuroprotective strategies are an unmet need. Due to their capability to transdifferentiate, to immune mo...

Descripción completa

Detalles Bibliográficos
Autores principales: de Munter, Johannes PJM, Lee, Chongsik, Wolters, Erik Ch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674952/
https://www.ncbi.nlm.nih.gov/pubmed/23734727
http://dx.doi.org/10.1186/2047-9158-2-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674952/
https://www.ncbi.nlm.nih.gov/pubmed/23734727
http://dx.doi.org/10.1186/2047-9158-2-13

Ejemplares similares